Rep. Slaughter Issues Statement on President-Elect Trump Considering Jim O'Neill to Lead FDA
December 08, 2016
December 08, 2016
WASHINGTON, Dec. 8 -- Rep. Louise Slaughter, D-N.Y. (25th CD), issued the following news release:
Congresswoman Louise M. Slaughter (NY-25), the only microbiologist in Congress, released this statement following reports that President-elect Donald Trump is considering venture capitalist Jim O'Neill to head the Food and Drug Administration (FDA). The FDA has broad regulatory authority that impacts everything from vaccines to medical devices and tobacco products to prescription and . . .
Congresswoman Louise M. Slaughter (NY-25), the only microbiologist in Congress, released this statement following reports that President-elect Donald Trump is considering venture capitalist Jim O'Neill to head the Food and Drug Administration (FDA). The FDA has broad regulatory authority that impacts everything from vaccines to medical devices and tobacco products to prescription and . . .